S. Takamura and T. Fukuda, “Dupilumab Achieves Early Disease Control in Bullous Pemphigoid: A Case Series with TARC-based Biomarker Evaluation”, Acta Derm Venereol, vol. 105, p. adv43999, Jul. 2025.